146 related articles for article (PubMed ID: 27474435)
1. Epigallocatechin-3-gallate attenuates cadmium-induced chronic renal injury and fibrosis.
Chen J; Du L; Li J; Song H
Food Chem Toxicol; 2016 Oct; 96():70-8. PubMed ID: 27474435
[TBL] [Abstract][Full Text] [Related]
2. Potential ameliorative effects of grape seed-derived polyphenols against cadmium induced prostatic deficits.
Lei Y; Chen Q; Chen J; Liu D
Biomed Pharmacother; 2017 Jul; 91():707-713. PubMed ID: 28499242
[TBL] [Abstract][Full Text] [Related]
3. Potential Ameliorative Effects of Qing Ye Dan Against Cadmium Induced Prostatic Deficits via Regulating Nrf-2/HO-1 and TGF-β1/Smad Pathways.
Du L; Lei Y; Chen J; Song H; Wu X
Cell Physiol Biochem; 2017; 43(4):1359-1368. PubMed ID: 28992620
[TBL] [Abstract][Full Text] [Related]
4. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Tipoe GL; Leung TM; Liong EC; Lau TY; Fung ML; Nanji AA
Toxicology; 2010 Jun; 273(1-3):45-52. PubMed ID: 20438794
[TBL] [Abstract][Full Text] [Related]
6. ShenKang injection suppresses kidney fibrosis and oxidative stress via transforming growth factor-β/Smad3 signalling pathway in vivo and in vitro.
Wu X; Guan Y; Yan J; Liu M; Yin Y; Duan J; Wei G; Hu T; Weng Y; Xi M; Wen A
J Pharm Pharmacol; 2015 Aug; 67(8):1054-65. PubMed ID: 25864844
[TBL] [Abstract][Full Text] [Related]
7. Potential ameliorative effects of epigallocatechin-3-gallate against cigarette smoke exposure induced renal and hepatic deficits.
Chen J; Liu J; Lei Y; Liu M
Ecotoxicol Environ Saf; 2020 Mar; 191():110202. PubMed ID: 31945511
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells.
Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B
Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510
[TBL] [Abstract][Full Text] [Related]
10. EGCG targeting Notch to attenuate renal fibrosis
Zhu QQ; Yang XY; Zhang XJ; Yu CJ; Pang QQ; Huang YW; Wang XJ; Sheng J
Food Funct; 2020 Nov; 11(11):9686-9695. PubMed ID: 33057539
[TBL] [Abstract][Full Text] [Related]
11. Effect of pre- and post-combined multidoses of epigallocatechin gallate and coenzyme Q10 on cisplatin-induced oxidative stress in rat kidney.
Fatima S; Al-Mohaimeed N; Arjumand S; Banu N; Al-Jameil N; Al-Shaikh Y
J Biochem Mol Toxicol; 2015 Feb; 29(2):91-7. PubMed ID: 25382014
[TBL] [Abstract][Full Text] [Related]
12. Asperuloside attenuates cadmium-induced toxicity by inhibiting oxidative stress, inflammation, fibrosis and apoptosis in rats.
Kong Z; Liu C; Olatunji OJ
Sci Rep; 2023 Apr; 13(1):5698. PubMed ID: 37029128
[TBL] [Abstract][Full Text] [Related]
13. A new update for radiocontrast-induced nephropathy aggravated with glycerol in rats: the protective potential of epigallocatechin-3-gallate.
Palabiyik SS; Dincer B; Cadirci E; Cinar I; Gundogdu C; Polat B; Yayla M; Halici Z
Ren Fail; 2017 Nov; 39(1):314-322. PubMed ID: 28100100
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy of oligonol, catechin and (-)-epigallocatechin 3-O-gallate in modulating the potassium bromate-induced renal toxicity in rats.
Nishioka H; Fujii H; Sun B; Aruoma OI
Toxicology; 2006 Sep; 226(2-3):181-7. PubMed ID: 16916569
[TBL] [Abstract][Full Text] [Related]
15. Assessing the effects of tempol on renal fibrosis, inflammation, and oxidative stress in a high-salt diet combined with 5/6 nephrectomy rat model: utilizing oxidized albumin as a biomarker.
Liu B; Hu Y; Tian D; Dong J; Li BF
BMC Nephrol; 2024 Feb; 25(1):64. PubMed ID: 38395806
[TBL] [Abstract][Full Text] [Related]
16. Activity of (-)-epigallocatechin 3-O-gallate against oxidative stress in rats with adenine-induced renal failure.
Nakagawa T; Yokozawa T; Sano M; Takeuchi S; Kim M; Minamoto S
J Agric Food Chem; 2004 Apr; 52(7):2103-7. PubMed ID: 15053559
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling.
Sriram N; Kalayarasan S; Manikandan R; Arumugam M; Sudhandiran G
Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):849-59. PubMed ID: 26010495
[TBL] [Abstract][Full Text] [Related]
18. Betaine supplementation protects against renal injury induced by cadmium intoxication in rats: role of oxidative stress and caspase-3.
Hagar H; Al Malki W
Environ Toxicol Pharmacol; 2014 Mar; 37(2):803-11. PubMed ID: 24632105
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration.
Kakuta Y; Okumi M; Isaka Y; Tsutahara K; Abe T; Yazawa K; Ichimaru N; Matsumura K; Hyon SH; Takahara S; Nonomura N
Transpl Int; 2011 May; 24(5):514-22. PubMed ID: 21291499
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy.
Zhou P; Yu JF; Zhao CG; Sui FX; Teng X; Wu YB
Mol Med Rep; 2013 Apr; 7(4):1096-102. PubMed ID: 23358654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
